GB2439618A - Skincare composition - Google Patents
Skincare composition Download PDFInfo
- Publication number
- GB2439618A GB2439618A GB0611743A GB0611743A GB2439618A GB 2439618 A GB2439618 A GB 2439618A GB 0611743 A GB0611743 A GB 0611743A GB 0611743 A GB0611743 A GB 0611743A GB 2439618 A GB2439618 A GB 2439618A
- Authority
- GB
- United Kingdom
- Prior art keywords
- composition
- range
- starch
- present
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 117
- 239000000516 sunscreening agent Substances 0.000 claims abstract description 38
- 230000000475 sunscreen effect Effects 0.000 claims abstract description 33
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 31
- 229920002472 Starch Polymers 0.000 claims abstract description 20
- 235000019698 starch Nutrition 0.000 claims abstract description 20
- 239000008107 starch Substances 0.000 claims abstract description 19
- 239000003906 humectant Substances 0.000 claims abstract description 18
- FQUNFJULCYSSOP-UHFFFAOYSA-N bisoctrizole Chemical compound N1=C2C=CC=CC2=NN1C1=CC(C(C)(C)CC(C)(C)C)=CC(CC=2C(=C(C=C(C=2)C(C)(C)CC(C)(C)C)N2N=C3C=CC=CC3=N2)O)=C1O FQUNFJULCYSSOP-UHFFFAOYSA-N 0.000 claims abstract description 16
- -1 compound salt Chemical class 0.000 claims abstract description 16
- XVAMCHGMPYWHNL-UHFFFAOYSA-N bemotrizinol Chemical compound OC1=CC(OCC(CC)CCCC)=CC=C1C1=NC(C=2C=CC(OC)=CC=2)=NC(C=2C(=CC(OCC(CC)CCCC)=CC=2)O)=N1 XVAMCHGMPYWHNL-UHFFFAOYSA-N 0.000 claims abstract description 15
- 239000000839 emulsion Substances 0.000 claims abstract description 12
- 230000001804 emulsifying effect Effects 0.000 claims abstract description 11
- 125000000129 anionic group Chemical group 0.000 claims abstract description 7
- 239000012874 anionic emulsifier Substances 0.000 claims abstract description 5
- 239000012875 nonionic emulsifier Substances 0.000 claims abstract description 5
- 230000000699 topical effect Effects 0.000 claims abstract description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 34
- 239000004615 ingredient Substances 0.000 claims description 28
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims description 28
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 27
- 229920000881 Modified starch Polymers 0.000 claims description 17
- 235000011187 glycerol Nutrition 0.000 claims description 17
- 235000019426 modified starch Nutrition 0.000 claims description 17
- 239000003921 oil Substances 0.000 claims description 16
- 235000019198 oils Nutrition 0.000 claims description 16
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- BANXPJUEBPWEOT-UHFFFAOYSA-N 2-methyl-Pentadecane Chemical compound CCCCCCCCCCCCCC(C)C BANXPJUEBPWEOT-UHFFFAOYSA-N 0.000 claims description 14
- CYSGHNMQYZDMIA-UHFFFAOYSA-N 1,3-Dimethyl-2-imidazolidinon Chemical compound CN1CCN(C)C1=O CYSGHNMQYZDMIA-UHFFFAOYSA-N 0.000 claims description 13
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 claims description 12
- 229960001679 octinoxate Drugs 0.000 claims description 12
- 150000005846 sugar alcohols Polymers 0.000 claims description 12
- 229940086555 cyclomethicone Drugs 0.000 claims description 11
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 claims description 11
- 229940008099 dimethicone Drugs 0.000 claims description 10
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims description 10
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 10
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 claims description 10
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 10
- 229940012831 stearyl alcohol Drugs 0.000 claims description 10
- UBNYRXMKIIGMKK-RMKNXTFCSA-N amiloxate Chemical compound COC1=CC=C(\C=C\C(=O)OCCC(C)C)C=C1 UBNYRXMKIIGMKK-RMKNXTFCSA-N 0.000 claims description 9
- 229940071160 cocoate Drugs 0.000 claims description 9
- 241001135917 Vitellaria paradoxa Species 0.000 claims description 8
- 235000018936 Vitellaria paradoxa Nutrition 0.000 claims description 8
- 229940081733 cetearyl alcohol Drugs 0.000 claims description 8
- DLAHAXOYRFRPFQ-UHFFFAOYSA-N dodecyl benzoate Chemical compound CCCCCCCCCCCCOC(=O)C1=CC=CC=C1 DLAHAXOYRFRPFQ-UHFFFAOYSA-N 0.000 claims description 8
- 229940043268 2,2,4,4,6,8,8-heptamethylnonane Drugs 0.000 claims description 7
- JDRSMPFHFNXQRB-CMTNHCDUSA-N Decyl beta-D-threo-hexopyranoside Chemical compound CCCCCCCCCCO[C@@H]1O[C@H](CO)C(O)[C@H](O)C1O JDRSMPFHFNXQRB-CMTNHCDUSA-N 0.000 claims description 7
- 150000003863 ammonium salts Chemical class 0.000 claims description 7
- 229940073499 decyl glucoside Drugs 0.000 claims description 7
- KUVMKLCGXIYSNH-UHFFFAOYSA-N isopentadecane Natural products CCCCCCCCCCCCC(C)C KUVMKLCGXIYSNH-UHFFFAOYSA-N 0.000 claims description 7
- 239000002480 mineral oil Substances 0.000 claims description 7
- 239000002304 perfume Substances 0.000 claims description 7
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 claims description 6
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 6
- 229930006000 Sucrose Natural products 0.000 claims description 6
- 125000001931 aliphatic group Chemical group 0.000 claims description 6
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 claims description 6
- 229940049964 oleate Drugs 0.000 claims description 6
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims description 6
- 229950011392 sorbitan stearate Drugs 0.000 claims description 6
- 239000005720 sucrose Substances 0.000 claims description 6
- 150000003626 triacylglycerols Chemical class 0.000 claims description 6
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 6
- 239000008158 vegetable oil Substances 0.000 claims description 6
- DGSZGZSCHSQXFV-UHFFFAOYSA-N 2,3-bis(2-ethylhexanoyloxy)propyl 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(OC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC DGSZGZSCHSQXFV-UHFFFAOYSA-N 0.000 claims description 5
- TYYHDKOVFSVWON-UHFFFAOYSA-N 2-butyl-2-methoxy-1,3-diphenylpropane-1,3-dione Chemical compound C=1C=CC=CC=1C(=O)C(OC)(CCCC)C(=O)C1=CC=CC=C1 TYYHDKOVFSVWON-UHFFFAOYSA-N 0.000 claims description 5
- 229910019142 PO4 Inorganic materials 0.000 claims description 5
- 229960005193 avobenzone Drugs 0.000 claims description 5
- 239000012188 paraffin wax Substances 0.000 claims description 5
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 5
- 239000010452 phosphate Substances 0.000 claims description 5
- 150000003242 quaternary ammonium salts Chemical class 0.000 claims description 5
- DBFHTTOOJDMDTI-KCMGSBMCSA-N C(CCCCCCCCCCCCCCCCC)(=O)O.CC(=O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.C(CCCCCCCCCCCCCCCCC)(=O)O.C(CCCCCCCCCCCCCCCCC)(=O)O.CC(=O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO Chemical compound C(CCCCCCCCCCCCCCCCC)(=O)O.CC(=O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.C(CCCCCCCCCCCCCCCCC)(=O)O.C(CCCCCCCCCCCCCCCCC)(=O)O.CC(=O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO DBFHTTOOJDMDTI-KCMGSBMCSA-N 0.000 claims description 4
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 4
- 229920001577 copolymer Polymers 0.000 claims description 4
- 229960005150 glycerol Drugs 0.000 claims description 4
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 claims description 4
- 229940075495 isopropyl palmitate Drugs 0.000 claims description 4
- 229940100486 rice starch Drugs 0.000 claims description 4
- 229920002545 silicone oil Polymers 0.000 claims description 4
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 3
- PWVUXRBUUYZMKM-UHFFFAOYSA-N 2-(2-hydroxyethoxy)ethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOCCO PWVUXRBUUYZMKM-UHFFFAOYSA-N 0.000 claims description 3
- ICIDSZQHPUZUHC-UHFFFAOYSA-N 2-octadecoxyethanol Chemical compound CCCCCCCCCCCCCCCCCCOCCO ICIDSZQHPUZUHC-UHFFFAOYSA-N 0.000 claims description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 3
- NWGKJDSIEKMTRX-AAZCQSIUSA-N Sorbitan monooleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-AAZCQSIUSA-N 0.000 claims description 3
- IYFATESGLOUGBX-YVNJGZBMSA-N Sorbitan monopalmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O IYFATESGLOUGBX-YVNJGZBMSA-N 0.000 claims description 3
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims description 3
- 239000003963 antioxidant agent Substances 0.000 claims description 3
- 235000006708 antioxidants Nutrition 0.000 claims description 3
- 229940073669 ceteareth 20 Drugs 0.000 claims description 3
- 229960000541 cetyl alcohol Drugs 0.000 claims description 3
- 239000002738 chelating agent Substances 0.000 claims description 3
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 3
- 229940074050 glyceryl myristate Drugs 0.000 claims description 3
- 229940075529 glyceryl stearate Drugs 0.000 claims description 3
- 239000004973 liquid crystal related substance Substances 0.000 claims description 3
- NJTGANWAUPEOAX-UHFFFAOYSA-N molport-023-220-454 Chemical compound OCC(O)CO.OCC(O)CO NJTGANWAUPEOAX-UHFFFAOYSA-N 0.000 claims description 3
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 3
- 229940077414 peg-12 stearate Drugs 0.000 claims description 3
- 239000003755 preservative agent Substances 0.000 claims description 3
- DCBSHORRWZKAKO-UHFFFAOYSA-N rac-1-monomyristoylglycerol Chemical compound CCCCCCCCCCCCCC(=O)OCC(O)CO DCBSHORRWZKAKO-UHFFFAOYSA-N 0.000 claims description 3
- 239000011734 sodium Substances 0.000 claims description 3
- 229910052708 sodium Inorganic materials 0.000 claims description 3
- 229950004959 sorbitan oleate Drugs 0.000 claims description 3
- 229950003429 sorbitan palmitate Drugs 0.000 claims description 3
- 229940100458 steareth-21 Drugs 0.000 claims description 3
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 3
- 229910021653 sulphate ion Inorganic materials 0.000 claims description 3
- 239000002562 thickening agent Substances 0.000 claims description 3
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 claims description 2
- 239000004368 Modified starch Substances 0.000 claims description 2
- 238000006243 chemical reaction Methods 0.000 claims description 2
- 238000004040 coloring Methods 0.000 claims description 2
- 239000003974 emollient agent Substances 0.000 claims description 2
- 239000003002 pH adjusting agent Substances 0.000 claims description 2
- 229940114930 potassium stearate Drugs 0.000 claims description 2
- ANBFRLKBEIFNQU-UHFFFAOYSA-M potassium;octadecanoate Chemical compound [K+].CCCCCCCCCCCCCCCCCC([O-])=O ANBFRLKBEIFNQU-UHFFFAOYSA-M 0.000 claims description 2
- 239000004408 titanium dioxide Substances 0.000 claims description 2
- 239000003381 stabilizer Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 16
- 230000005855 radiation Effects 0.000 abstract description 5
- 210000003491 skin Anatomy 0.000 description 40
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- 230000006378 damage Effects 0.000 description 7
- 239000012071 phase Substances 0.000 description 7
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 6
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 6
- 229920002125 Sokalan® Polymers 0.000 description 6
- 229960001631 carbomer Drugs 0.000 description 6
- 239000006071 cream Substances 0.000 description 6
- 238000009472 formulation Methods 0.000 description 6
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 6
- 229960005323 phenoxyethanol Drugs 0.000 description 6
- 239000000230 xanthan gum Substances 0.000 description 6
- 229920001285 xanthan gum Polymers 0.000 description 6
- 235000010493 xanthan gum Nutrition 0.000 description 6
- 229940082509 xanthan gum Drugs 0.000 description 6
- GUOCOOQWZHQBJI-UHFFFAOYSA-N 4-oct-7-enoxy-4-oxobutanoic acid Chemical compound OC(=O)CCC(=O)OCCCCCCC=C GUOCOOQWZHQBJI-UHFFFAOYSA-N 0.000 description 5
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 5
- 239000004411 aluminium Substances 0.000 description 5
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 5
- 229910052782 aluminium Inorganic materials 0.000 description 5
- UZKWTJUDCOPSNM-UHFFFAOYSA-N 1-ethenoxybutane Chemical compound CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 4
- 239000008346 aqueous phase Substances 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- 210000000434 stratum corneum Anatomy 0.000 description 4
- 229960001295 tocopherol Drugs 0.000 description 4
- 229930003799 tocopherol Natural products 0.000 description 4
- 235000010384 tocopherol Nutrition 0.000 description 4
- 239000011732 tocopherol Substances 0.000 description 4
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 4
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical class NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 3
- AKUPYGILGNUOIG-UHFFFAOYSA-N 5-methoxy-4-phenyltriazine Chemical compound COC1=CN=NN=C1C1=CC=CC=C1 AKUPYGILGNUOIG-UHFFFAOYSA-N 0.000 description 3
- 125000005250 alkyl acrylate group Chemical group 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000003750 conditioning effect Effects 0.000 description 3
- 229920006037 cross link polymer Polymers 0.000 description 3
- 230000018044 dehydration Effects 0.000 description 3
- 238000006297 dehydration reaction Methods 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 210000002615 epidermis Anatomy 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 235000019271 petrolatum Nutrition 0.000 description 3
- 230000004224 protection Effects 0.000 description 3
- 230000037067 skin hydration Effects 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- ISDGWTZFJKFKMO-UHFFFAOYSA-N 2-phenyl-1,3-dioxane-4,6-dione Chemical compound O1C(=O)CC(=O)OC1C1=CC=CC=C1 ISDGWTZFJKFKMO-UHFFFAOYSA-N 0.000 description 2
- RMTFNDVZYPHUEF-XZBKPIIZSA-N 3-O-methyl-D-glucose Chemical compound O=C[C@H](O)[C@@H](OC)[C@H](O)[C@H](O)CO RMTFNDVZYPHUEF-XZBKPIIZSA-N 0.000 description 2
- 229920002261 Corn starch Polymers 0.000 description 2
- 239000004264 Petrolatum Substances 0.000 description 2
- 208000000453 Skin Neoplasms Diseases 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 239000008163 avocado oil Substances 0.000 description 2
- 235000021302 avocado oil Nutrition 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 229940085262 cetyl dimethicone Drugs 0.000 description 2
- 239000008120 corn starch Substances 0.000 description 2
- 210000004207 dermis Anatomy 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 235000008524 evening primrose extract Nutrition 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 229930182478 glucoside Natural products 0.000 description 2
- 150000008131 glucosides Chemical class 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 239000008172 hydrogenated vegetable oil Substances 0.000 description 2
- 229940119170 jojoba wax Drugs 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000007764 o/w emulsion Substances 0.000 description 2
- OQILCOQZDHPEAZ-UHFFFAOYSA-N octyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OCCCCCCCC OQILCOQZDHPEAZ-UHFFFAOYSA-N 0.000 description 2
- 229940066842 petrolatum Drugs 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000003352 sequestering agent Substances 0.000 description 2
- 229940057910 shea butter Drugs 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- WQKLGQXWHKQTPO-UXRZSMILSA-N (2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-methoxyoxane-3,4,5-triol;2-(2-hydroxypropoxy)propan-1-ol Chemical compound CC(O)COC(C)CO.CC(O)COC(C)CO.CC(O)COC(C)CO.CC(O)COC(C)CO.CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O WQKLGQXWHKQTPO-UXRZSMILSA-N 0.000 description 1
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical class C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- CUAJPFGLNDCFAH-UHFFFAOYSA-N 1,1-di(propan-2-yl)cyclohexane Chemical compound CC(C)C1(C(C)C)CCCCC1 CUAJPFGLNDCFAH-UHFFFAOYSA-N 0.000 description 1
- JLHMJWHSBYZWJJ-UHFFFAOYSA-N 1,2-thiazole 1-oxide Chemical compound O=S1C=CC=N1 JLHMJWHSBYZWJJ-UHFFFAOYSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- ZQCIPRGNRQXXSK-UHFFFAOYSA-N 1-octadecoxypropan-2-ol Chemical compound CCCCCCCCCCCCCCCCCCOCC(C)O ZQCIPRGNRQXXSK-UHFFFAOYSA-N 0.000 description 1
- RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 description 1
- ILCOCZBHMDEIAI-UHFFFAOYSA-N 2-(2-octadecoxyethoxy)ethanol Chemical compound CCCCCCCCCCCCCCCCCCOCCOCCO ILCOCZBHMDEIAI-UHFFFAOYSA-N 0.000 description 1
- LSHGMOIQPURPAK-UHFFFAOYSA-N 2-benzylidene-1,4,7,7-tetramethylbicyclo[2.2.1]heptan-3-one Chemical compound CC1(C)C(C2=O)(C)CCC1(C)C2=CC1=CC=CC=C1 LSHGMOIQPURPAK-UHFFFAOYSA-N 0.000 description 1
- OPJWPPVYCOPDCM-UHFFFAOYSA-N 2-ethylhexyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(CC)CCCC OPJWPPVYCOPDCM-UHFFFAOYSA-N 0.000 description 1
- GTJOHISYCKPIMT-UHFFFAOYSA-N 2-methylundecane Chemical compound CCCCCCCCCC(C)C GTJOHISYCKPIMT-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- AMEMLELAMQEAIA-UHFFFAOYSA-N 6-(tert-butyl)thieno[3,2-d]pyrimidin-4(3H)-one Chemical compound N1C=NC(=O)C2=C1C=C(C(C)(C)C)S2 AMEMLELAMQEAIA-UHFFFAOYSA-N 0.000 description 1
- XZOYHFBNQHPJRQ-UHFFFAOYSA-N 7-methyloctanoic acid Chemical compound CC(C)CCCCCC(O)=O XZOYHFBNQHPJRQ-UHFFFAOYSA-N 0.000 description 1
- KGKQNDQDVZQTAG-UHFFFAOYSA-N 8-methylnonyl 2,2-dimethylpropanoate Chemical compound CC(C)CCCCCCCOC(=O)C(C)(C)C KGKQNDQDVZQTAG-UHFFFAOYSA-N 0.000 description 1
- UOFXSBOAZYCBAV-UHFFFAOYSA-N 8-methylnonyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCCCC(C)C UOFXSBOAZYCBAV-UHFFFAOYSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- LVDKZNITIUWNER-UHFFFAOYSA-N Bronopol Chemical compound OCC(Br)(CO)[N+]([O-])=O LVDKZNITIUWNER-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 240000002024 Gossypium herbaceum Species 0.000 description 1
- 235000004341 Gossypium herbaceum Nutrition 0.000 description 1
- 244000020551 Helianthus annuus Species 0.000 description 1
- 235000003222 Helianthus annuus Nutrition 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- SGVYKUFIHHTIFL-UHFFFAOYSA-N Isobutylhexyl Natural products CCCCCCCC(C)C SGVYKUFIHHTIFL-UHFFFAOYSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 235000004496 Oenothera biennis Nutrition 0.000 description 1
- 240000008916 Oenothera biennis Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- WYWZRNAHINYAEF-UHFFFAOYSA-N Padimate O Chemical compound CCCCC(CC)COC(=O)C1=CC=C(N(C)C)C=C1 WYWZRNAHINYAEF-UHFFFAOYSA-N 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 244000025272 Persea americana Species 0.000 description 1
- 235000011236 Persea americana var americana Nutrition 0.000 description 1
- 229920002413 Polyhexanide Polymers 0.000 description 1
- 244000044822 Simmondsia californica Species 0.000 description 1
- 235000004433 Simmondsia californica Nutrition 0.000 description 1
- 239000004288 Sodium dehydroacetate Substances 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- 244000141804 Theobroma grandiflorum Species 0.000 description 1
- 235000002424 Theobroma grandiflorum Nutrition 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- PHYFQTYBJUILEZ-UHFFFAOYSA-N Trioleoylglycerol Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC PHYFQTYBJUILEZ-UHFFFAOYSA-N 0.000 description 1
- 230000006750 UV protection Effects 0.000 description 1
- LPGFSDGXTDNTCB-UHFFFAOYSA-N [3-(16-methylheptadecanoyloxy)-2,2-bis(16-methylheptadecanoyloxymethyl)propyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC(C)C)(COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C LPGFSDGXTDNTCB-UHFFFAOYSA-N 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 229960004050 aminobenzoic acid Drugs 0.000 description 1
- 239000012164 animal wax Substances 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229960004101 bemotrizinol Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- 150000008366 benzophenones Chemical class 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229960003168 bronopol Drugs 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 239000000828 canola oil Substances 0.000 description 1
- 235000019519 canola oil Nutrition 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 229920003090 carboxymethyl hydroxyethyl cellulose Polymers 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- CMDKPGRTAQVGFQ-RMKNXTFCSA-N cinoxate Chemical compound CCOCCOC(=O)\C=C\C1=CC=C(OC)C=C1 CMDKPGRTAQVGFQ-RMKNXTFCSA-N 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000002844 continuous effect Effects 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- SOROIESOUPGGFO-UHFFFAOYSA-N diazolidinylurea Chemical compound OCNC(=O)N(CO)C1N(CO)C(=O)N(CO)C1=O SOROIESOUPGGFO-UHFFFAOYSA-N 0.000 description 1
- 229960001083 diazolidinylurea Drugs 0.000 description 1
- TVWTZAGVNBPXHU-FOCLMDBBSA-N dioctyl (e)-but-2-enedioate Chemical compound CCCCCCCCOC(=O)\C=C\C(=O)OCCCCCCCC TVWTZAGVNBPXHU-FOCLMDBBSA-N 0.000 description 1
- KCIDZIIHRGYJAE-YGFYJFDDSA-L dipotassium;[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] phosphate Chemical compound [K+].[K+].OC[C@H]1O[C@H](OP([O-])([O-])=O)[C@H](O)[C@@H](O)[C@H]1O KCIDZIIHRGYJAE-YGFYJFDDSA-L 0.000 description 1
- GLCJMPWWQKKJQZ-UHFFFAOYSA-L disodium;2-[4-(4,6-disulfonato-1h-benzimidazol-2-yl)phenyl]-1h-benzimidazole-4,6-disulfonate;hydron Chemical compound [Na+].[Na+].C1=C(S(O)(=O)=O)C=C2NC(C3=CC=C(C=C3)C3=NC4=C(C=C(C=C4N3)S(=O)(=O)O)S([O-])(=O)=O)=NC2=C1S([O-])(=O)=O GLCJMPWWQKKJQZ-UHFFFAOYSA-L 0.000 description 1
- WSDISUOETYTPRL-UHFFFAOYSA-N dmdm hydantoin Chemical compound CC1(C)N(CO)C(=O)N(CO)C1=O WSDISUOETYTPRL-UHFFFAOYSA-N 0.000 description 1
- HUVYTMDMDZRHBN-UHFFFAOYSA-N drometrizole trisiloxane Chemical compound C[Si](C)(C)O[Si](C)(O[Si](C)(C)C)CC(C)CC1=CC(C)=CC(N2N=C3C=CC=CC3=N2)=C1O HUVYTMDMDZRHBN-UHFFFAOYSA-N 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- UVCJGUGAGLDPAA-UHFFFAOYSA-N ensulizole Chemical compound N1C2=CC(S(=O)(=O)O)=CC=C2N=C1C1=CC=CC=C1 UVCJGUGAGLDPAA-UHFFFAOYSA-N 0.000 description 1
- 229940045761 evening primrose extract Drugs 0.000 description 1
- 229940089020 evening primrose oil Drugs 0.000 description 1
- 239000010475 evening primrose oil Substances 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- 230000036074 healthy skin Effects 0.000 description 1
- ZUVCYFMOHFTGDM-UHFFFAOYSA-N hexadecyl dihydrogen phosphate Chemical compound CCCCCCCCCCCCCCCCOP(O)(O)=O ZUVCYFMOHFTGDM-UHFFFAOYSA-N 0.000 description 1
- 229920006007 hydrogenated polyisobutylene Polymers 0.000 description 1
- 229920001477 hydrophilic polymer Polymers 0.000 description 1
- 239000001341 hydroxy propyl starch Substances 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 235000013828 hydroxypropyl starch Nutrition 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229940040923 isodecyl laurate Drugs 0.000 description 1
- VKPSKYDESGTTFR-UHFFFAOYSA-N isododecane Natural products CC(C)(C)CC(C)CC(C)(C)C VKPSKYDESGTTFR-UHFFFAOYSA-N 0.000 description 1
- 229940033357 isopropyl laurate Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 150000001455 metallic ions Chemical class 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 229940042472 mineral oil Drugs 0.000 description 1
- 239000012184 mineral wax Substances 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 229960003921 octisalate Drugs 0.000 description 1
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical group C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 description 1
- 229960000601 octocrylene Drugs 0.000 description 1
- WCJLCOAEJIHPCW-UHFFFAOYSA-N octyl 2-hydroxybenzoate Chemical compound CCCCCCCCOC(=O)C1=CC=CC=C1O WCJLCOAEJIHPCW-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- 229960001173 oxybenzone Drugs 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 229940057874 phenyl trimethicone Drugs 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229940078491 ppg-15 stearyl ether Drugs 0.000 description 1
- 229940116393 ppg-20 methyl glucose ether Drugs 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- VZKNAUXVJXVEAG-UHFFFAOYSA-N propan-2-yl hexadecanoate;propan-2-yl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OC(C)C.CCCCCCCCCCCCCCCC(=O)OC(C)C VZKNAUXVJXVEAG-UHFFFAOYSA-N 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000001944 prunus armeniaca kernel oil Substances 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 150000003902 salicylic acid esters Chemical class 0.000 description 1
- 230000037075 skin appearance Effects 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 229960003885 sodium benzoate Drugs 0.000 description 1
- 235000019259 sodium dehydroacetate Nutrition 0.000 description 1
- 229940079839 sodium dehydroacetate Drugs 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- RYYKJJJTJZKILX-UHFFFAOYSA-M sodium octadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC([O-])=O RYYKJJJTJZKILX-UHFFFAOYSA-M 0.000 description 1
- DSOWAKKSGYUMTF-GZOLSCHFSA-M sodium;(1e)-1-(6-methyl-2,4-dioxopyran-3-ylidene)ethanolate Chemical compound [Na+].C\C([O-])=C1/C(=O)OC(C)=CC1=O DSOWAKKSGYUMTF-GZOLSCHFSA-M 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- CRPCXAMJWCDHFM-UHFFFAOYSA-M sodium;5-oxopyrrolidine-2-carboxylate Chemical compound [Na+].[O-]C(=O)C1CCC(=O)N1 CRPCXAMJWCDHFM-UHFFFAOYSA-M 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 229940098760 steareth-2 Drugs 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000036561 sun exposure Effects 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 235000020238 sunflower seed Nutrition 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 150000003918 triazines Chemical class 0.000 description 1
- LINXHFKHZLOLEI-UHFFFAOYSA-N trimethyl-[phenyl-bis(trimethylsilyloxy)silyl]oxysilane Chemical compound C[Si](C)(C)O[Si](O[Si](C)(C)C)(O[Si](C)(C)C)C1=CC=CC=C1 LINXHFKHZLOLEI-UHFFFAOYSA-N 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 239000012178 vegetable wax Substances 0.000 description 1
- 239000007762 w/o emulsion Substances 0.000 description 1
- 239000008307 w/o/w-emulsion Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/496—Triazoles or their condensed derivatives, e.g. benzotriazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4966—Triazines or their condensed derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/731—Cellulose; Quaternized cellulose derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/732—Starch; Amylose; Amylopectin; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/54—Polymers characterized by specific structures/properties
- A61K2800/542—Polymers characterized by specific structures/properties characterized by the charge
- A61K2800/5426—Polymers characterized by specific structures/properties characterized by the charge cationic
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Cosmetics (AREA)
Abstract
A skincare composition in the form of an emulsion comprising: <SL> <LI>a) a sunscreen component comprising at least one organic sunscreen selected from the group consisting of bis-ethylhexyloxyphenol methoxyphenyl triazine and methylene bis-benzotriazolyl tetramethylbutylphenol; <LI>b) a moisturising system comprising starch or a derivative thereof and a polymeric quaternary compound salt having humectant properties; and <LI>c) an emulsifying system comprising at least one emulsifier comprising an anionic or non-ionic emulsifier. </SL> The topical compositions have advantageous properties in protecting the skin against the effects of sunlight, especially UV radiation.
Description
<p>I</p>
<p>Skincare Composition The present invention relates to a composition for topical application which protects the skin from the effects of sunlight, in particular to a skincare composition in the form of an emulsion which provides a moisturising and sunscreen effect.</p>
<p>Radiation from the sun plays a major role in damaging one or more skin layers, for example the effect of the heat rays drying out the skin and the effect of UV rays in penetrating into the deeper levels of the skin. There are many different types of rays present in sunlight. UVB rays are responsible for causing sunburn where significant damage and dehydration of the skin occurs, and also may lead to skin cancers. UVA rays also contribute to skin cancer but additionally lead to a photoageing effect where the skin loses its healthy and youthful appearance. In the dermis, the collagen and elastin fibres which provide the skin with strength, structure and elasticity, are broken down by exposure to UV radiation, leading to wrinkles and sagging skin. The UV damage may occur at any time of year as the UVA rays, which penetrate more deeply into the skin than UVB rays, pass though glass.</p>
<p>In addition, exposure to UV light may affect lipids in the outer layer of the skin causing the cells in the stratum corneum to adhere poorly to each other, providing that the new skin continuously being formed has an impaired skin barrier.</p>
<p>Furthermore, destruction of the lipids, which generally form a strong protective barrier acting to preserve the moisture in the body, may also cause the skin cells to lose the water they need to stay healthy and supple. A healthy stratum corneum comprises about 30% water, giving the skin resilience and elasticity.</p>
<p>Accordingly, it is desired to moisturise skin exposed to UV light to retain its healthy function.</p>
<p>Numerous products have been provided to protect the skin from the effect of exposure to the sun. These products include organic and/or inorganic sunscreens. Many of the organic sunscreens which mop up the free radicals are unstable when formulated and do not provide protection for a prolonged period. In particular, great care must be taken to minimise the amount of ingredients to reduce the likelihood of the system being unstable, If the formulation does not provide adequate protection from the sun, the epidermis is a primary location at which damage occurs. Damage to the epidermis, including dehydration, increases the damage to the lower layers of the dermis and also the intercellular matrix between the layers.</p>
<p>The present invention seeks to provide an improved suncare formulation. It has now been found that by providing an effective sunscreen component in combination with a particular moisturising system, advantages in the protection and overall appearance of the skin are achieved.</p>
<p>Accordingly, the present invention provides a skincare composition in the form of an emulsion comprising: a) a sunscreen component comprising at least one organic sunscreen selected from the group consisting of bis-ethylhexyloxyphenol methoxyphenyl triazine and methylene bis-benzotriazolyl tetramethylbutylphenol; b) a moisturising system comprising starch or a derivative thereof and a polymeric quaternary compound salt having humectant properties; and c) an emulsifying system comprising at least one emulsifier comprising an anionic or non-ionic emulsifier.</p>
<p>The present invention has allowed the formation of a stable sunscreen system in a formulation which is able to provide a continuous moisturisation effect. The moisturisation effect is maintained at continuous levels for a period of 12 hours or more. The continuous effect is particularly desirable as it significantly reduces the dehydration of the skin on exposure to sunlight and maximises the rehydration and moisturisation of the skin. A healthy skin with a properly functioning outer barrier layer exposed to the environment is better able to withstand the effects of exposure to sunlight than dehydrated, damaged skin. Advantages of the present invention include a stable and effective sunscreen formulation which not only reduces the effect of UV radiation on the skin from UV damage but also prevents it from drying out. In particular, not only do compositions according to the invention prevent substantial moisture loss, through the continuous addition of moisture over a period of 12 hours or more, the epidermal layer of the skin is healthier and is better able to withstand the effects of UV radiation. Accordingly, an advantageous UV protection effect may be obtained. The compositions are advantageously used daily to maximize their effect.</p>
<p>The sunscreen component useful in accordance with the present invention comprises at least one organic sunscreen selected from the group consisting of bis-ethylhexyloxyphenol methoxyphenyl triazine and methylene bis-benzotriazolyl tetramethylbutylphenol. Additional sunscreen agents may also be combined with said sunscreens, including p-aminobenzoic acids, esters and derivatives thereof, for example, 2-ethylhexyl p-dimethylaminobenzoate and the octyl ester of p- aminobenzoic acid; methoxycinnamate esters such as 2-ethylhexyl p- methoxycinnamate, 2-ethoxyethyl p-methoxycinnamate or a, 13-di-(p-methoxycinnamoyl)-a'-(2-ethylhexanoyl)...glycerin; benzophenones such as oxybenzone; 2-phenylbenzimidazole-5-sulfonic acid and disodium phenyl dibenzimidazole tetrasulfonate and terphthalylidene dicamphor sulfonic acid; alkyl- 3,3-diphenylacrylates for example alkyl a-cyano-3-diphenylacrylates such as octocrylene; triazines such as 2,4,6-trianilino-(p-carbo-2-ethylhexyl-1 -oxy)-1,3,5 triazine; camphor derivatives such as methylbenzylidene camphor; silicone derivatives such as drometrizole trisiloxane, benzylidene malonate polysiloxane and dimethicodiethyl benzal malonate and salicylates such as octyl salicylate.</p>
<p>In one embodiment, the sunscreen component comprises bis-ethylhexyloxyphenol methoxyphenyl triazine in combination with one or more of methylene bis- benzotriazolyl tetramethylbutylphenol, ethylhexyl methoxycinnamate, isoamyl p-methoxycinnamate and butyl methoxydibenzoylmethane. In another embodiment, the sunscreen component comprises methylene bis-benzotriazolyl tetramethylbutyiphenol in combination with one or more of bis-ethylhexyloxyphenol methoxyphenyl triazine, ethylhexylmethoxy cinnamate, isoamyl p-methoxycinnamate and butyl methoxydibenzoylmethane. Preferably, the sunscreen component comprises a combination of bis-ethylhexyloxyphenol methoxyphenyl triazine, methylene bis-benzotriazolyl tetramethylbutylphenol and ethylhexylmethoxy cinnamate, optionally including isoamyl p-methoxycinnamate.</p>
<p>Preferably, a composition according to the invention comprises a sunscreen component in an amount greater than 2.5% w/w, more preferably greater than 5% w/w and most preferably greater than 10% w/w. Further preferably, the sunscreen agent is present in the composition in an amount less than 25% w/w, more preferably less than 20% w/w and most preferably less than 10% w/w.</p>
<p>Accordingly, in particularly preferred compositions, the sunscreen component is present in the composition in the range 2.5% to 25% w/w, more preferably in the range 5% to 20% w/w and most preferably in the range 10% to 18% w/w.</p>
<p>If desired, a composition according to the present invention may also comprise an inorganic sunscreen agent, preferably titanium dioxide. Said inorganic sunscreen agent, if present, is preferably used in the range I % to 10% w/w, more preferably in the range 2% to 8% w/w and most preferably in the range 3% to 7% w/w.</p>
<p>A composition according to the invention comprises a moisturising system comprising starch or a derivative thereof and a polymeric quaternary compound salt having humectant properties. The starch or starch derivative is preferably a chemically or physically modified starch. Most preferably, the starch is modified so as to render it heat-stable and/or non-swelling.</p>
<p>A preferred form of starch derivative is a dimethyl imidazolidinone starch derivative, ie a product obtained by reaction of I,3-dimethyl-4,5-dihydroxy-2-imidazolidinone (dimethyl imidazolidinone) with starch. Particular starches that may be used include corn starch but, more preferably, the starch is rice starch.</p>
<p>The dimethyl imidazolidinone starch derivative may thus be dimethylimidazolidinone corn starch or, more preferably, dimethylimidazolidinone rice starch.</p>
<p>A suitable form of dimethylimidazolidinone rice starch is available from Agrana U. Staerke AG, Conrathstr. 7, A-3950 Gmuend, Austria, under the trade name Rice NS. Another supplier is Dr Hauser, Reintalstrasse 8, D-82467 Garmisch-Partenkirchen, Germany.</p>
<p>The starch or starch derivative is preferably present in the composition according to the invention at a level of less than 15% w/w, preferably less than 10% w/w, and more preferably less than 5% w/w. The concentration of starch derivative is preferably greater than 0.1 % w/w, and more preferably greater than I % w/w. The concentration of starch derivative is therefore preferably in the range 0.1 % to 15% w/w, and more preferably in the range I % to 5% w/w, particularly in the range 2.25% to 3.75% w/w.</p>
<p>The polymeric quaternary ammonium salt is most preferably the material known as Polyquaternium-51, ie the polymeric quaternary ammonium salt that conforms generally to the formula: --+ -</p>
<p>-_____________ -___ -</p>
<p>c=o c=o (CH2)3 0 CH3 I I --y 13-P-O(CH2)21-cH3 -0 CH3 A suitable form of polyquaternium-51 is available from NOF Corporation, 4-20-3, Ebisu, Shibuya-ku, Tokyo 150, Japan, under the trade name Lipidure-PMB.</p>
<p>The ammonium salt is preferably present in the composition according to the invention at a level of less than 1% w/w, more preferably less than 0.1 % w/w. The concentration of ammonium salt is preferably greater than 0.0001% w/w, and more preferably greater than 0.001% w/w. The concentration of ammonium salt is therefore preferably in the range 0.0001% to 1% w/w, and more preferably in the range 0.001% to 0.1% w/w.</p>
<p>The composition according to the invention may comprise one or more additional moisturising or humectant ingredients, ie moisturising or humectant ingredients that are additional to the starch derivative and the ammonium salt.</p>
<p>Most preferably, the additional moisturising or humectant ingredient is a relatively low molecular weight polyalcohol, eg a C26 aliphatic polyalcohol. Examples of such polyalcohols include glycerin (1,2,3-trihydroxypropane), I,3-butylene glycol and propylene glycol. The most preferred additional moisturising or humectant ingredient is glycerin.</p>
<p>The additional moisturising or humectant ingredient(s) are preferably present in the composition at a level of up to 25% w/w or more, more preferably up to 20% w/w. The concentration of additional moisturising or humectant ingredient(s) is preferably greater than I % w/w, more preferably greater than 5% w/w, and most preferably greater than 10% w/w. The concentration of additional moisturising or humectant ingredient(s) is therefore preferably in the range 1% to 25% w/w, and more preferably in the range 5% to 20% wlw.</p>
<p>Where glycerin is present in the composition, the concentration of glycerin is preferably in the range 1% to 20% w/w, more preferably in the range 10% to 20% w/w, and in particular in the range 10% to 15% w/w.</p>
<p>The composition may comprise more than one aliphatic polyalcohol. In some embodiments, the composition comprises both glycerin and propylene glycol.</p>
<p>Compositions comprising one or more aliphatic polyalcohols have been found to be particularly beneficial. In a more specific aspect, the invention thus provides a composition for topical application to the skin, which composition comprises a starch or starch derivative, a polymeric quaternary ammonium salt having humectant properties, and from 10% to 20% w/w of one or more aliphatic polyalcohols. The polyalcohols are preferably C2..6 aliphatic polyalcohols, most preferably selected from the group consisting of glycerin (1,2,3-trihydroxypropane), 1,3-butylene glycol and propylene glycol. Preferably, the composition comprises glycerin.</p>
<p>In preferred embodiments, the composition is free of any additional moisturising agents other than the low molecular weight polyalcohols. In particular, the composition is preferably free of sodium PCA, urea, trehalose and sodium hyaluronate.</p>
<p>In preferred composition according to the present invention, the ratio of moisturising system to sunscreen component is in the range 1:1 to 1:20 parts by weight, more preferably 1:2 to 1:10 parts by weight, most preferably 1:4 to 1:6 parts by weight.</p>
<p>A composition according to the present invention is in the form of an emulsion, preferably a water-in-oil emulsion. Preferably, the oil component comprises: hydrocarbons, silicone oils, triglycerides, waxes, glycerin, fatty acids, fatty acid alcohols and esters thereof, mineral oils, vegetable oils and hydrogenated vegetable oils, lanolin or mixtures thereof. Examples of hydrocarbons include paraffins (for example paraffinum liquidum and white soft paraffin), petrolatum, hydrogenated polyisobutene, alkyl benzoates, isohexadecane, isododecane, isononyl isonanoate, diisopropylcyclohexane; examples of silicone oils include dimethicone, cyclomethicone, cetyldimethicone or stearyl dimethicone, examples of triglycerides include natural triglycerides and synthetic or semi-synthetic triglycerides including caprilic/capric triglyceride; examples of waxes include vegetable waxes such as carnauba wax, animal waxes such as beeswax,and mineral waxes such as paraffin wax, ozokerite; examples of esters of fatty acids or alcohols include isopropyl palmitate, isopropyl myristate, dioctylmaleate, glyceryl oleate and cetostearyl isononanoate, octyl palmitate, cetearyl alcohol, stearyl alcohol, cetyl alcohol, glyceryl Myristate, decyl cocoate:examples of mineral oils include Vaseline oil; examples of vegetable oils include jojoba oil, soy bean oil, coconut oil, sunflower seed oil, apricot kernel oil, shea butter, avocado oil and examples of hydrogenated vegetable oils include hydrogenated palm oil.</p>
<p>The cosmetically oil chosen for any composition may depend on the type of composition desired. Preferred classes of oils include silicone oils, mineral oils, vegetable oils and triglycerides, especially mineral oils and vegetable oils.</p>
<p>Particularly preferred oils are butyrospermum parkii, caprilic/capric triglyceride, Cl 2-15 alkyl benzoate, isohexadecane, triethylhexanoin, cyclomethicone, dimethicone, glycerin, cetearyl alcohol, isopropylpalmitate, stearyl alcohol, cetyl alcohol, stearyl dimethicone, glyceryl myristate, paraffinum liquidum, acrylates copolymer and decyl cocoate or mixtures thereof. Especially preferred is a combination of glycerin, Cl 2-15 alkyl benzoate, caprilic/capric triglyceride, cyclomethicone and stearyl alcohol, optionally in combination with one or more oils identified above.</p>
<p>Preferably, said oil is present in an amount in the range 4% to 50% w/w, more preferably in the range 6% to 30% w/w and most preferably in the range 8% to 20% w/w.</p>
<p>Preferably, water is present in the composition in the range 20% to 80% w/w, more preferably in the range 25% to 75% w/w and most preferably in the range 35% to 55% w/w. JL) 9</p>
<p>An emulsifying system useful in accordance with the present invention comprises at least one emulsifier comprising an anionic or non-ionic emulsifier. Typical classes of these emulsifiers are known to those skilled in the art. Optionally, the emulsifier may be combined with a thickening agent.</p>
<p>Preferably, the emulsifying system comprises a combination of emulsifiers with different HLB values, more preferably at least one emulsifier with a high HLB value and at least one emulsifier with a low-medium HLB value, especially preferably at least one emulsifier with a high HLB value and at least one emulsifier with a low HLB value. In one embodiment, the mixture of emulsifiers may comprise a combination of one or more anionic emulsifiers with one or more non-ionic emulsifiers. In another embodiment, the mixture may comprise a combination of anionic emulsifiers. In another embodiment, the mixture may comprise a combination of non-ionic emulsifiers.</p>
<p>The emulsifying system is preferably present in the composition in an amount in the range 0.01% to 20% w/w, preferably 0.1% to 15% w/w, most preferably 1-10% w/w.</p>
<p>In preferred composition according to the present invention, the emulsifying system comprises a liquid crystal forming system, preferably a high level of liquid crystals. Suitably, the emulsifying system comprises at least one high HLB emulsifier and at least one low-medium HLB emulsifier. Examples of high HLB emulsifiers include: methylglucose sesquistearate, sucrose cocoate, decyl glucoside, potassium stearate, isolaureth-4 phosphate, steareth-21, stearete-lO, ceteareth-12, ceteareth-20, oleth-lO, polyglyceryl-3 methylgiucose distearate, sodium cetearyl sulphate, PEG-12 oleate, PEG-12 stearate or PEG-80 sorbitan.</p>
<p>Typically, the high HLB emulsifier is present in an amount in the range 0.01% to 10% w/w, more preferably in the range 0.1% to 5% w/w.</p>
<p>Examples of low-medium HLB emulsifiers include stearyl alcohol, sorbitan stearate, cetearyl alcohol, glyceryl stearate, stearate-2, ceteareth-5, polyglyceryl-3 oleate, PEG-2 stearate, sorbitan oleate sorbitan palmitate or cetyl PEG/PPG/-1 9/1 dimethicone. Typically, a low-medium HLB emulsifier may be present in the composition in an amount in the range 0.1% to 10% w/w, more preferably in the range 0.5% to 5% w/w.</p>
<p>Conveniently, the emulsifiers used may be selected from one or more of sorbitan stearate, sucrose cocoate, methyl glucose desquistearate, cetyl phosphate, dicetyiphosphate, ceteth-lO phosphate, cetearyl alcohol, glyceryl stearate, cetearyl glucoside, especially methylglucose sesquistearate, stearyl alcohol, sucrose cocoate and sorbitan stearate. The combinations of methylglucose sesquistearate/stearyl alcohol or sucrose cocoate/ sorbitan stearate are particularly preferred.</p>
<p>Optionally other emulsifiers may also be incorporated in compositions according to the invention including steareth-2, steareth-21, steareth-lO, ceteareth-5, ceteareth-12, ceteareth-20, oleth-lO, polyglyceryl-3 oleate, polyglyceryl-3 methylglucose distearate, sodium cetearyl sulphate, sodium stearate, PEG-12 Oleate, PEG-2 stearate, PEG-12 stearate, sorbitan oleate, sorbitan palmitate an cetyl PEG/PPG-10/1 dimethicone.</p>
<p>Suitably, thickeners include hydrophilic polymers and derivatives thereof, eg agarose, carbomer, polyacrylamide, alkyl acrylate crosspolymer, carboxymethyl hydroxyethylcellulose, hydroxyethyl cellulose, xanthan gum, cellulose gum, and hydroxypropyl starch.</p>
<p>Compositions in accordance with the invention may be formulated in any one of numerous different forms. Suitable types of composition, and methods by which they may be prepared, will generally be evident to those skilled in the art.</p>
<p>Compositions according to the invention are formulated as emulsions. The emulsions may be o/w, w/o, o/w/o or w/o/w emulsions. Preferred emulsion compositions are o/w emulsions. Such emulsion-type compositions may be described inter a/ia as creams or lotions. Other emulsion compositions are wlo emulsions.</p>
<p>As moisturisation of the skin is an important benefit of the compositions according to the invention, additional ingredients that contribute to improved skin-feel are preferably present. Such additional ingredients may include skin conditioning agents.</p>
<p>Suitable skin conditioning agents that may be present include ingredients having emollient properties, ie ingredients which help to maintain the soft, smooth and pliable appearance of the skin, and which function by their ability to remain on the skin surface or in the stratum corneum to act as lubricants, to reduce flaking and to improve the skin's appearance. Suitable skin conditioning ingredients will be evident to those skilled in the art, but examples include PPG-15 stearyl ether, ethylhexyl stearate, cetyl dimethicone, octyldodecanol, PPG-20 methyl glucose ether, isopropyl myristate isopropyl palmitate, isopropyl laurate isodecyl laurate, isodecyl neopentanoate, isohexadecane, pentaerythrityl tetraisostearate, caprylic/capric triglyceride, canola oil, sunflower oil (Helianthus annuus), olive oil (O/ea europea), cottonseed oil (Gossypium herbaceum), jojoba oil (Simmondsia chinensis), shea butter (Butyrospermum parki!), cocoa butter (Theobroma cacao), cupuacu butter (Theobroma grandiflorum), avocado oil (Persea gratissima), evening primrose oil (Oenothera biennis), mineral oil, liquid paraffin, squalane, dimethicone, phenyl trimethicone, cyclomethicone, cyclopentasiloxane, dimethiconol and petrolatum.</p>
<p>The composition will generally also comprise other ingredients or excipients which constitute or form part of a dermatologically acceptable carrier and will be well known to those skilled in the art. These include, for example: a) Chelating agents or sequestering agents (sequestrants) -ingredients that have the ability to complex with and inactivate metallic ions in order to prevent their adverse effects on the stability or appearance of the composition. Examples of chelating agents are ethylenediamine tetraacetic acid and its salts, notably the dipotassium and especially the disodium or tetrasodium salt.</p>
<p>b) Preservatives -ingredients which prevent or retard microbial growth and thus protect the composition from spoilage. Examples of preservatives include DMDM hydantoin, propylparaben, methylparaben, phenoxyethanol, sodium benzoate, bronopol, sodium dehydroacetate, polyhexamethylenebiguanide hydrochloride, isothiazolone and diazolidinylurea.</p>
<p>C) Perfumes and colourings.</p>
<p>d) pH adjusting agents; and e) Anti-oxidants.</p>
<p>As described above, the compositions according to the invention are useful in that they enhance the moisturisation of the skin. Accordingly, in another aspect the invention provides methods for protecting the skin or for regulating the condition of the skin, which method comprises the topical application to the skin of a composition as herein described. In particular, the above methods protect the skin from the effects of sunlight and/or improve the appearance of the skin following exposure to sunlight. The skin to which the composition is applied will most commonly be human skin, the composition generally being applied by the user to his or her own skin. Usually, the composition will be applied to areas of skin that are normally exposed, eg the face and/or neck, the arms, hands or legs. A composition according to the invention is applied to the skin for example by rubbing or massaging into the skin, preferably before exposure to the sun for example 20-30 minutes before sun exposure.</p>
<p>In a yet further aspect of the invention, there is provided the use of a moisturising system comprising starch or a derivative thereof and a polymeric quaternary compound salt having humectant properties in the preparation of a skincare composition in the form of an emulsion having an emulsifying system comprising an anionic or non-ionic emulsifier and a sunscreen component comprising at least one organic sunscreen selected from the group consisting of bis-ethylhexyloxyphenol methoxyphenyl triazine and methylene bis-benzotriazolyl tetramethylbutyiphenol.</p>
<p>The present invention also provides a process to prepare a composition as previously described comprising combining said sunscreen component with an oily phase and homogenously mixing with an aqueous phase. In the process, further ingredients may be incorporated into the oil phase/ aqueous phase before and/or after mixing with said active ingredient. One or more active ingredients may be added at different stages of the process. Either or both the oil and aqueous phases may be heated before being combined, for example to a temperature in the range 50-100 C.</p>
<p>In the following examples, there are described several preferred embodiments to illustrate the invention. However, it is to be understood that the invention is not to be limited to the specific embodiments.</p>
<p>In the examples, Methylene Bis-benzotriazolyl Tetramethylbutylphenol and Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine are available from Ciba Speciality Chemicals, D-79630 Grenzach-Wyhlen, Germany, under the trade names Tinosorb M and Tinosorb S respectively; Ethyihexyl Methoxycinnamate and Isoamyl p-Methoxycinnamate are available from Symrise, D20354 Hamburg, Germany under the trade names Parsol MCX and Neo Heliopan E 1000, respectively.</p>
<p>ExamDle 1: Cream lnQredient % w/w Glycerin 12.0 Isopropylpalmitate 5.0 C12-15 Alkyl Benzoate 4.0 Isoamyl p-Methoxycinnamate 3.75 Ethylhexyl Methoxycinnamate 3.716 Caprylic/Capric Triglyceride 3.5 Aluminium Starch Octenylsuccinate 3.0 Dimethylimidazolidinone Rice Starch 2.5 Methylene Bis-benzotriazolyl Tetramethylbutylphenol 2.5 Cyclomethicone 2.0 Methyl Glucose Sesquistearate 2.0 Stearylalcohol 2.0 Bis-Ethyihexyloxyphenol Methoxyphenyl Triazine 1.9 Phenoxyethanol 1.0 Parfum 0.5 Decyl Glucoside 0.45 Sodium Hydroxide 0.05 Carbomer 0.12 Propylene Glycol 0.025 Xanthan Gum 0.025 Polyquaternium-51 0.01 BHT 0.003 Water to 100% Method The sunscreens, excepting Methylene Bis-benzotriazolyl Tetramethylbutylphenol, the emulsifiers and other oily ingredients were combined to form the oil phase.</p>
<p>The moisturising system was combined with the water and water-soluble ingredients to form thee aqueous phase. The oil and water phases were independently heated to 70 -80 C and the oil phase admixed with the water phase.</p>
<p>The two phases were homogenised and cooled with careful stirring. Ingredients sensitive on temperature, including Methylene Bis-benzotriazolyl Tetramethylbutylphenol, were then added to the emulsion at room temperature and the pH adjusted.</p>
<p>ExamDle 2: Cream Ingredient % W/W Glycerin 12.0 Sorbitan Stearate 5.09 C12-15 Alkyl Benzoate 5.0 Ethyihexyl Methoxycinnamate 7.433 Caprylic/Capric Triglyceride 3.0 Aluminium Starch Octenylsuccinate 3.0 Isohexadecane 3.0 Dimethylimidazolidinone Rice Starch 2.5 Methylene Bis-benzotriazolyl Tetramethylbutylphenol 2.5 Cyclomethicone 2.0 Cetearyl Alcohol 1.0 Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine 1.9 Butyrospermum parkii 1.0 Phenoxyethanol 1.0 Parfum 0.5 Decyl Glucoside 0.45 Sucrose Cocoate 0.41 Xanthan Gum 0.125 Tocopherol 0.1 Carbomer 0.120 EDTA 0.05 Sodium Hydroxide 0.04 Propylene Glycol 0.025 Polyquaternium-51 0.01 BHT 0.007 Water to 100% Method The composition of Example 2 was prepared in a similar manner to that described</p>
<p>in Example 1.</p>
<p>Example 3: Cream</p>
<p>Inciredient %w/w Glycerin 10.53 C12-15 Alkyl Benzoate 8.0 Ethylhexyl Methoxycinnamate 4.96 Propylene Glycol 4.0 Cyclomethicone 4.0 Caprylic/Capric Triglyceride 3.5 Aluminium Starch Octenylsuccinate 3.0 Triethylhexanoin 3.0 Cetearyl Alcohol 3.0 Dimethylimidazolidinone Rice Starch 2.5 Isohexadecane 2.5 Glyceryl Stearte SE 2.0 Bis-Ethyihexyloxyphenol Methoxyphenyl Triazine 1.7 Titanium Dioxide 2.4 Methylene Bis-benzotriazolyl Tetramethylbutylphenol 1.4 Cetearyl Glucoside 1.25 Butyrospermum parkii 1.0 Phenoxyethanol 1.0 Parfum 0.5 Decyl Glucoside 0.25 lsolaureth-4 Phosphate 0.3 PEG-25 Butyl Vinylether I Sodium Maleate Copolymer 0.3 Carbomer 0.12 Tocopherol 0.1 Sodium Hydroxide 0.06 EDTA 0.05 Xanthan Gum 0.014 Polyquaternium-51 0.01 BHT 0.005 Butylmethoxydibenzoyl methane 1.5 Water to 100% Method The composition of Example 3 was prepared in a similar manner to that described</p>
<p>in Example 1.</p>
<p>ExamDle 4: Cream Ingredient % wlw Glycerin 12.0 C12-15 Alkyl Benzoate 6.0 Ethylhexyl Methoxycinnamate 4.459 Caprylic/Capric Triglyceride 3.5 Aluminium Starch Octenylsuccinate 3.0 Dimethylimidazolidinone Rice Starch2.5 Isohexadecane 2.5 Cyclomethicone 2.0 Triethylhexanoin 2.0 Methylene Bis-benzotriazolyl Tetramethylbutylphenol 2.0 Bis-Ethyihexyloxyphenol Methoxyphenyl Triazine 1.9 Butyrospermum parkii 1.0 Phenoxyethanol 1.0 Parfum 0.5 Decyl Glucoside 0.36 Acrylates/C10-30 Alkyl Acrylate Crosspolymer 0.2 Carbomer 0.2 Tocopherol 0.1 EDTA 0.05 Sodium Hydroxide 0.03 Propylene Glycol 0.025 Xanthan Gum 0.02 Polyquaternium-51 0.01 BHT 0.005 Water to 100% Method The composition of Example 4 was prepared in a similar manner to that described</p>
<p>in Example 1.</p>
<p>ExamDle 5: Cream lniredient % w/w Glycerin 12.0 C12-lSAlkyI Benzoate 6.0 Ethylhexyl Methoxycinnamate 3.996 Caprylic/Capric Triglyceride 3.5 Aluminium Starch Octenylsuccinate 3.0 Dimethylimidazolidinone Rice Starch 2.5 Cyclomethicone 2.0 Triethylhexanoin 2.0 Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine 1.7 Methylene Bis-benzotriazolyl Tetramethylbutylphenol 1.4 Butyrospermum parkii 1.0 Phenoxyethanol 1.0 Parfum 0.5 Decyl Glucoside 0.25 Acrylates/C 10-30 Alkyl Acrylate Crosspolymer 0.2 lsolaureth-4 Phosphate 0.1875 PEG- 25 Butyl Vinylether I Sodium Maleate Copolymer 0.1875 Carbomer 0.18 Tocopherol 0.1 EDTA 0.05 Sodium Hydroxide 0.04 Propylene Glycol 0.014 Xanthan Gum 0.014 Polyquaternium-51 0.01 BHT 0.004 Water to 100% Method The composition of Example 5 was prepared in a similar manner to that described</p>
<p>in Example 1.</p>
<p>Clinical Trial The continuous moisturisation effect of Examples I and 2 was measured using a standard Corneometer CM 825. The method by which moisturisation is measured is based on the dielectric constant of water. Due to the high dielectric constant of water, the dielectric characteristics of the stratum corneum are related to the water content. Assuming constant frequency, temperature and structure of the skin surface, an increase of capacitance correlates with an increase in skin hydration.</p>
<p>The study was conducted double blind on 30 female volunteers with dry skin. The investigation sites were localised at the inner sides of both forearms. The skin hydration was measured immediately before product application (t zero), after 2 hours, 4 hours, 6 hours, 8 hours and 12 hours.</p>
<p>--20 The results below represent the skin hydration relative to t zero (=1) and how it changes over time.</p>
<p>Times of control 2 hrs 4 hrs 6 hrs 8 hrs 10 hrs j 12 hrs Example 1 1,50 1,50 1,46 1,41 1,40 1,39 Example 2 1,47 1,43 1,43 1,39 1,38 1,37 It can be seen that both formulations exhibited an advantageous continuous moisturisation profile. In addition, both formulations were deemed to provide valuable sunscreen profiles.</p>
Claims (3)
- <p>Claims 1. A skincare composition in the form of an emulsion comprising:a) a sunscreen component comprising at least one organic sunscreen selected from the group consisting of bis-ethylhexyloxyphenol methoxyphenyl triazine and methylene bis-benzotriazolyl tetramethylbutylphenol; b) a moisturising system comprising starch or a derivative thereof and a polymeric quaternary compound salt having humectant properties; and C) an emulsifying system comprising at least one emulsifier comprising an anionic or non-ionic emulsifier.</p><p>2. A composition as claimed in Claim I wherein the sunscreen component comprises bis-ethylhexyloxyphenol methoxyphenyl triazine in combination with one or more of methylene bis-benzotriazolyl tetramethylbutyiphenol, ethylhexyl methoxycinnamate, isoamyl p-methoxycinnamate and butyl methoxydibenzoylmethane.</p><p>3. A composition as claimed in Claim 1 wherein the sunscreen component comprises methylene bis-benzotriazolyl tetramethylbutylphenol in combination with one or more of bis-ethylhexyloxyphenol methoxyphenyl triazine, ethylhexylmethoxy cinnamate, isoamyl p-methoxycinnamate and butyl methoxydibenzoylmethane.</p><p>4. A composition as claimed in any preceding claim wherein the sunscreen component comprises a combination of bis-ethylhexyloxyphenol methoxyphenyl triazine, methylene bis-benzotriazolyl tetramethylbutylphenol and ethylhexylmethoxy cinnamate, optionally including isoamyl p-methoxycinnamate.</p><p>5. A composition as claimed in any preceding claim comprising said sunscreen component in an amount greater than
- 2.5% wlw, more preferably greater than 5% w/w and most preferably greater than 10% w/w.</p><p>6. A composition as claimed in any preceding claim comprising said sunscreen component in an amount less than 25% w/w, more preferably less than 20% w/w, more preferably less than 10% w/w.</p><p>7. A composition as claimed in any preceding claim wherein the sunscreen component is present in the range 2.5% to 25% w/w, more preferably in the range 5% to 20% w/w and most preferably in the range 10% to 18% w/w.</p><p>8. A composition according to any preceding claim further comprising an inorganic sunscreen agent, preferably titanium dioxide.</p><p>9. A composition according to Claim 8 wherein said inorganic sunscreen agent is present in the range I % to 10% w/w, more preferably in the range 2% to 8% w/w and most preferably in the range 3% to 7% w/w.</p><p>10. A composition as claimed in any preceding claim, wherein the starch or starch derivative is a chemically or physically modified starch.</p><p>11. A composition as claimed in any preceding claim, wherein the starch derivative is a product obtained by reaction of I,3-dimethyl-4,5-dihydroxy-2-imidazolidinone (dimethyl imidazolidinone) with starch.</p><p>12. A composition as claimed in any preceding claim, wherein the starch derivative is dimethylimidazolidinone rice starch.</p><p>13. A composition as claimed in any preceding claim, wherein the starch or starch derivative is present in the composition at a level of less than 15% w/w, preferably less than 10% w/w, and more preferably less than 5% w/w.</p><p>14. A composition as claimed in any preceding claim, wherein the starch derivative is present in the composition at a level of greater than 0.1% w/w, and more preferably greater than I % w/w.</p><p>15. A composition as claimed in any preceding claim, wherein the concentration of starch derivative is in the range 0.1% to 15% w/w, and more preferably in the range 1% to 5% w/w, particularly 2.25% to
- 3. 75% w/w.</p><p>16. A composition as claimed in any preceding claim, wherein the polymeric quaternary ammonium salt is Polyquaternium-51, ie the polymeric quaternary ammonium salt that conforms generally to the formula: --IjH -______________ -.0H2?--0=0 a (OH2)3 0 OH3 I I --, 0-P-O(0H2 -0 OH3 17. A composition as claimed in any preceding claim, wherein the ammonium salt is present in the composition at a level of less than I % w/w, more preferably less than 0.1% w/w.</p><p>18. A composition as claimed in any preceding claim, wherein the ammonium salt is present in the composition at a level greater than 0.0001% w/w, and more preferably greater than 0.001 % w/w.</p><p>19. A composition as claimed in any preceding claim, wherein the concentration of ammonium salt is in the range 0.0001% to 1% w/w, and more preferably in the range 0.001% to 0.1% w/w.</p><p>20. A composition as claimed in any preceding claim, wherein the ratio of moisturising system to sunscreen component is in the range 1:1 to 1:20 parts by weight, more preferably 1:2 to 1:10 parts by weight, most preferably 1:4 to 1:6 parts by weight.</p><p>21. A composition as claimed in any preceding claim, which further comprises one or more additional moisturising or humectant ingredients.</p><p>22. A composition as claimed in Claim 21, wherein the additional moisturising or humectant ingredient is a relatively low molecular weight polyalcohol, eg a C26 aliphatic polyalcohol.</p><p>23. A composition as claimed in Claim 22, wherein the polyalcohol is selected from the group consisting of glycerin (1,2,3-trihydroxypropane), I,3-butylene glycol and propylene glycol.</p><p>24. A composition as claimed in any one of Claims 21 to 23, wherein the additional moisturising or humectant ingredients are present in the composition at a concentration of up to 25% w/w or more, more preferably up to 20% w/w.</p><p>25. A composition as claimed in any one of Claims 21 to 24, wherein the additional moisturising or humectant ingredient(s) are present in the composition at a level of greater than I % w/w, more preferably greater than 5% w/w, and most preferably greater than 10% w/w.</p><p>26. A composition as claimed in any one of Claims 21 to 25, wherein the concentration of additional moisturising or humectant ingredient(s) is in the range 1% to 25% w/w, and more preferably in the range 10% to 20% w/w, and in particular in the range 10% to 15% wlw.</p><p>27. A composition as claimed in any preceding claim, which comprises glycerin.</p><p>28. A composition as claimed in any preceding claim wherein the oil comprises one or more of silicone oils, mineral oils, vegetable oils and triglycerides, especially mineral oils and vegetable oils, preferably butyrospermum parkii, caprilic/capric triglyceride, C12-15 alkyl benzoate, isohexadecane, triethylhexanoin, cyclomethicone, dimethicone, glycerin, cetearyl alcohol, isopropylpalmitate, stearyl alcohol, cetyl alcohol, stearyl dimethicone, glyceryl myristate, paraffinum liquidum, acrylates copolymer and decyl cocoate or mixtures thereof and most preferably a combination of glycerin, C12-15 alkyl benzoate, caprilic/capric triglyceride, cyclomethicone and stearyl alcohol, optionally in combination with one or more further oils.</p><p>29. A composition as claimed in any preceding claim wherein said oil is present in an amount in the range 4% to 50% w/w, more preferably in the range 6% to 30% w/w and most preferably in the range 8% to 20% w/w.</p><p>30. A composition as claimed in any preceding claim wherein said water is present in an amount in the range 20% to 80% w/w, more preferably in the range 25% to 75% w/w and most preferably in the range 35% to 55% w/w.</p><p>31. A composition as claimed in any preceding claim, wherein the emulsifying system comprises a liquid crystal forming system.</p><p>32. A composition as claimed in any preceding claim, wherein the emulsifying system comprises at least one high HLB emulsifier and at least one low-medium HLB emulsifier.</p><p>33. A composition as claimed in Claim 32 wherein the high HLB emulsifier comprises one or more of methylglucose sesquistearate, sucrose cocoate, decyl glucoside, potassium stearate, isolaureth-4 phosphate, steareth-21, stearete-lO, ceteareth-1 2, ceteareth-20, oleth-1 0, polyglyceryl-3 methylglucose distearate, sodium cetearyl sulphate, PEG-12 oleate, PEG-12 stearate or PEG-80 sorbitan.</p><p>34. A composition as claimed in either one of Claims 32 or 33 wherein the high HLB emulsifier is present in an amount in the range 0. 01% to 10% w/w, more preferably in the range 0.1% to 5% w/w.</p><p>35. A composition as claimed in Claim 32 wherein the low-medium HLB emulsifier comprises stearyl alcohol, sorbitan stearate, cetearyl alcohol, glyceryl stearate, stearate-2, ceteareth-5, polyglyceryl-3 oleate, PEG-2 stearate, sorbitan oleate sorbitan palmitate or cetyl PEG/PPG/-19/1 dimethicone.</p><p>36. A composition as claimed in Claim 35 wherein the low-medium emulsifier is present in the composition in an amount in the range 0.1% to 10% w/w, more preferably in the range 0.5% to 5% w/w.</p><p>37. A composition as claimed in any preceding claim, which further comprises one or more emollients and/or thickeners.</p><p>38. A composition as claimed in any preceding claim, which further comprises one or more ingredients selected from the group consisting of: a) skin conditioners; b) stabilizers; c) chelating agents; d) anti-oxidants; e) preservatives; f) perfumes and colourings; g) pH adjusting agents; and h) anti-oxidants.</p><p>39. A method for moisturising skin, which method comprises the topical application to the skin of a composition as claimed in any preceding claim.</p>
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0611743A GB2439618A (en) | 2006-06-14 | 2006-06-14 | Skincare composition |
PCT/GB2007/050333 WO2007144670A1 (en) | 2006-06-14 | 2007-06-13 | Moisturising and sunscreen skincare composition |
EP20070733754 EP2040667A1 (en) | 2006-06-14 | 2007-06-13 | Moisturising and sunscreen skincare composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0611743A GB2439618A (en) | 2006-06-14 | 2006-06-14 | Skincare composition |
Publications (2)
Publication Number | Publication Date |
---|---|
GB0611743D0 GB0611743D0 (en) | 2006-07-26 |
GB2439618A true GB2439618A (en) | 2008-01-02 |
Family
ID=36775606
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0611743A Withdrawn GB2439618A (en) | 2006-06-14 | 2006-06-14 | Skincare composition |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP2040667A1 (en) |
GB (1) | GB2439618A (en) |
WO (1) | WO2007144670A1 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013114004A1 (en) * | 2012-01-31 | 2013-08-08 | Pierre Fabre Dermo-Cosmetique | Composition and combination of photostabilising bmdbm sunscreens |
WO2014023481A3 (en) * | 2012-08-06 | 2014-04-03 | Unilever N.V. | A photostable sunscreen composition |
WO2017220254A1 (en) * | 2016-06-21 | 2017-12-28 | Unilever N.V. | Skin care composition |
CN108670905A (en) * | 2018-07-17 | 2018-10-19 | 赵宏伟 | It is a kind of to have both sun-proof and after-sun function liquid crystal type lotion and preparation method |
FR3102672A1 (en) * | 2019-11-05 | 2021-05-07 | Jean-Noël Thorel | Water resistant solar composition with a high content of triazines |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2853255B1 (en) * | 2013-09-27 | 2018-11-28 | HallStar Beauty and Personal Care Innovations Company | Method of formulating a personal care product with substantially no whitening effect when applied on wet skin and compositions thereof |
AU2015202610A1 (en) * | 2014-05-30 | 2015-12-17 | Johnson & Johnson Consumer Companies, Inc. | Deodorant antiperspirant compositions |
CN109512682B (en) * | 2018-12-29 | 2022-03-25 | 浙江大学华南工业技术研究院 | Multiple emulsion with function of protecting natural water-soluble pigment, preparation method and application thereof |
JP2022522684A (en) * | 2019-02-27 | 2022-04-20 | エルジー ハウスホールド アンド ヘルスケア リミテッド | UV blocking cosmetic composition whose UV blocking efficiency is increased by UV rays |
KR102026658B1 (en) * | 2019-02-27 | 2019-09-30 | 주식회사 엘지생활건강 | A Sunscreen Cosmetic Formulation with Increased UV absorption efficiency by UV light |
CN111265459B (en) * | 2020-03-12 | 2022-07-15 | 广东袋鼠妈妈生物科技有限公司 | Sunscreen lotion for children and preparation method thereof |
CN112516022B (en) * | 2020-12-03 | 2022-08-12 | 深圳市琉璃光生物科技有限公司 | Sun-screening lotion and preparation method thereof |
CN112791004A (en) * | 2021-01-28 | 2021-05-14 | 上海好肌茵生物科技有限公司 | Coated sunscreen composition and sunscreen emulsion composed of same |
CN115487103B (en) * | 2021-11-02 | 2024-02-23 | 上海丽舒丹医药科技有限公司 | Plant-derived sun-screening synergistic agent composition and application thereof |
CN116035924B (en) * | 2023-03-07 | 2023-06-16 | 广州华淼生物科技研究院有限公司 | Oil-in-water emulsion suitable for spraying, preparation method thereof and spraying |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1371359A2 (en) * | 2002-06-13 | 2003-12-17 | Beiersdorf AG | Cosmetic and dermatological sunscreening compositions containing UV-absorbers, inorganic pigments and organic dyes |
US20050266055A1 (en) * | 2002-08-23 | 2005-12-01 | Beiersdorf Ag | Low-viscosity cosmetic or dermatological preparations |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5013763A (en) * | 1987-11-30 | 1991-05-07 | The Andrew Jergens Company | Wash-off-resistant skin preparation |
GB9403451D0 (en) * | 1994-02-23 | 1994-04-13 | Ciba Geigy Ag | Sunscreen compositions |
DE19543730A1 (en) * | 1995-11-23 | 1997-05-28 | Ciba Geigy Ag | Until resorcinyl-triazines |
US20030215471A1 (en) * | 2001-01-31 | 2003-11-20 | Wilmott James M. | Surfactant free topical compositions and method for rapid preparation thereof |
DE10140536A1 (en) * | 2001-08-17 | 2003-02-27 | Beiersdorf Ag | Cosmetic and dermatological light protection formulations containing benzotriazoles and iminodisuccinic acid and / or their salts |
DE102004025357B4 (en) * | 2004-05-19 | 2007-03-29 | Beiersdorf Ag | Emulsion concentrate with water-soluble and oil-soluble polymers and cosmetic preparation containing emulsion concentrate and a process for its preparation and its use |
WO2006061661A1 (en) * | 2004-12-11 | 2006-06-15 | Reckitt & Coleman (Overseas) Limited | Skincare compositions |
-
2006
- 2006-06-14 GB GB0611743A patent/GB2439618A/en not_active Withdrawn
-
2007
- 2007-06-13 EP EP20070733754 patent/EP2040667A1/en not_active Withdrawn
- 2007-06-13 WO PCT/GB2007/050333 patent/WO2007144670A1/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1371359A2 (en) * | 2002-06-13 | 2003-12-17 | Beiersdorf AG | Cosmetic and dermatological sunscreening compositions containing UV-absorbers, inorganic pigments and organic dyes |
US20050266055A1 (en) * | 2002-08-23 | 2005-12-01 | Beiersdorf Ag | Low-viscosity cosmetic or dermatological preparations |
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013113746A3 (en) * | 2012-01-31 | 2014-07-10 | Pierre Fabre Dermo-Cosmetique | Composition and association of sunscreens for photostabilizing butyl methoxydibenzoylmethane (bmdbm) |
US9814660B2 (en) | 2012-01-31 | 2017-11-14 | Pierre Fabre Dermo-Cosmetique | Composition and association of sunscreens for photostabilizing butyl methoxydibenzoylmethane (BMDBM) |
EP3299009A1 (en) * | 2012-01-31 | 2018-03-28 | Pierre Fabre Dermo-Cosmétique | Composition and association of sunscreens for photostabilizing butyl methoxydibenzoylmethane (bmdbm) |
WO2013114004A1 (en) * | 2012-01-31 | 2013-08-08 | Pierre Fabre Dermo-Cosmetique | Composition and combination of photostabilising bmdbm sunscreens |
WO2014023481A3 (en) * | 2012-08-06 | 2014-04-03 | Unilever N.V. | A photostable sunscreen composition |
JP2015524454A (en) * | 2012-08-06 | 2015-08-24 | ユニリーバー・ナームローゼ・ベンノートシヤープ | Photostable sunscreen composition |
US9295625B2 (en) | 2012-08-06 | 2016-03-29 | Conopco, Inc. | Photostable sunscreen composition |
EA032495B1 (en) * | 2012-08-06 | 2019-06-28 | Юнилевер Н.В. | Photostable sunscreen composition |
CN109310593B (en) * | 2016-06-21 | 2021-10-12 | 联合利华知识产权控股有限公司 | Skin care compositions |
WO2017220254A1 (en) * | 2016-06-21 | 2017-12-28 | Unilever N.V. | Skin care composition |
CN109310593A (en) * | 2016-06-21 | 2019-02-05 | 荷兰联合利华有限公司 | Skin care compositions and methods |
US10709652B2 (en) | 2016-06-21 | 2020-07-14 | Conopco, Inc. | Skin care composition |
CN108670905A (en) * | 2018-07-17 | 2018-10-19 | 赵宏伟 | It is a kind of to have both sun-proof and after-sun function liquid crystal type lotion and preparation method |
CN108670905B (en) * | 2018-07-17 | 2021-02-05 | 唯美爱科技(中国)有限公司 | Liquid crystal type emulsion with sun-screening and after-sun repairing functions and preparation method thereof |
FR3102672A1 (en) * | 2019-11-05 | 2021-05-07 | Jean-Noël Thorel | Water resistant solar composition with a high content of triazines |
EP3818973A1 (en) * | 2019-11-05 | 2021-05-12 | Thorel, Jean-Noël | Water-resistant solar composition with high triazine content |
Also Published As
Publication number | Publication date |
---|---|
EP2040667A1 (en) | 2009-04-01 |
GB0611743D0 (en) | 2006-07-26 |
WO2007144670A1 (en) | 2007-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2439618A (en) | Skincare composition | |
EP2968100B1 (en) | Combination of alkylamidothiazoles and preservatives | |
US7416719B2 (en) | Sunscreen compositions | |
EP2969028B1 (en) | Compositions of alkylamidothiazoles and uv filter substances | |
JP2003113020A (en) | Cosmetic and dermatological composition in form of water-oil emulsion containing amino-substituted hydroxybenzophenone | |
JP2002501014A (en) | Cosmetic or dermatological preparations with low lipid flow | |
JP2003095850A (en) | Cosmetic and dermatological preparation in form of o/w emulsion comprising amino-substituted hydroxybenzophenone | |
US6858200B2 (en) | Sunscreen formulations | |
KR102490647B1 (en) | Cosmetic Composition for UV and Bule-light Protection | |
US11497942B2 (en) | Cosmetic or dermatological preparation comprising a combination of a dye and an anti-inflammatory active ingredient | |
PT1216692E (en) | Use of alpha-cehc in cosmetic preparations | |
EP2969027B1 (en) | Compositions of alkylamidothiazoles and fragrances | |
KR102451738B1 (en) | Cosmetic composition for sunscreen comprising polysaccharide thickener and method for preparing same | |
DE10128910A1 (en) | Combination of arginine and ascorbic acid is used in the production of cosmetic or dermatological compositions for tightening and/or strengthening the skin, especially in cellulite treatment | |
US20210145722A1 (en) | Active substance combinations of n-(4-amino-2-methylquinolin-6-yl)-2-((4-ethylphenoxy)methyl)benzamide and one or more cosmetically or dermatologically acceptable fragrances | |
KR100884480B1 (en) | Solid-type wax-free cosmetic composition for blocking ultraviolet ray | |
WO2006061661A1 (en) | Skincare compositions | |
KR102122720B1 (en) | Cosmetic Composition for UV and Bule-light Protection | |
EP3122321B1 (en) | Photostable sunscreen composition for topical application | |
US20210186838A1 (en) | Active substance combinations of n-(4-amino-2-methylquinolin-6-yl)-2-((4-ethylphenoxy)methyl)benzamide and one or more cosmetically or dermatologically acceptable preservatives and/or preservative auxiliaries | |
KR20220002298A (en) | Cosmetic composition in the form of oil-in-water emulsion | |
CA2398038A1 (en) | Burnet extract | |
EP1416911B1 (en) | Personal care compositions | |
DE10002725A1 (en) | Treatment and prevention of undesired skin pigmentation, e.g. to prevent tanning or to remove freckles, using an ectoin compound, especially ectoin or hydroxyectoin | |
US7118760B2 (en) | Esters of aryl benzimidazole sulfonic acids and sunscreen compositions containing same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |